Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Pharmaceutical Technology Europe ; 34(2):4, 2022.
Article in English | ProQuest Central | ID: covidwho-20236725
2.
Pharmaceutical Technology Europe ; 33(12):4, 2021.
Article in English | ProQuest Central | ID: covidwho-20236724
3.
Applied Clinical Trials ; 30(7/8):2, 2021.
Article in English | ProQuest Central | ID: covidwho-20236723
4.
LC GC North America ; 39(7):307, 2021.
Article in English | ProQuest Central | ID: covidwho-20236722

ABSTRACT

Early on, whispers of a potentially engineered virus grew and fueled speculation that China was behind the pandemic-speculation so pervasive that, in February 2020, a group of 27 public health scientists published a letter in The Lancet disputing the laboratory leak theory, and announcing their support of their counterparts in China-the scientists, public health officials, and medical professionals-combating the pandemic. Robert Malone, MD, the inventor of the mRNA technology, has expressed strong concern over the risk-benefit analysis of vaccinating young adults, and the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has met to discuss cases of myocarditis or pericarditis in people aged 30 and younger who have received an mRNA Covid-19 vaccine. What we do know for certain is that the incredible strength and collaboration of the scientific community have allowed us to regain some semblance of normalcy.

5.
Pharmaceutical Technology Europe ; 33(7):6, 2021.
Article in English | ProQuest Central | ID: covidwho-20236721

ABSTRACT

Robert Malone, an mRNA researcher, appeared on television recently, expressing strong concern over the risk-benefit analysis of vaccination for young adults (3), and the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recently met to discuss instances of myocarditis or pericarditis in people aged 30 and younger who have received an mRNA COVID-19 vaccine. What we do know for certain is that the incredible strength and collaboration of the scientific community have allowed us to regain some semblance of normalcy. The development and rollout of multiple effective vaccine options have been the medical miracle of our lifetime.

6.
Contemporary Pediatrics TI -...And a healthy new year! ; 37(12):10 ST -...And a healthy new year!, 2020.
Article in English | ProQuest Central | ID: covidwho-20236720
7.
Contemporary Pediatrics ; 38(2):7, 2021.
Article in English | ProQuest Central | ID: covidwho-2323563
8.
Contemporary Pediatrics ; 37(9):5, 2020.
Article in English | ProQuest Central | ID: covidwho-2323562
9.
Oncology ; 2021.
Article in English | ProQuest Central | ID: covidwho-2296381

ABSTRACT

By New Year's Day 2021, millions of Americans had received the vaccine, including frontline physicians and health care providers and nursing home patients, our most vulnerable citizens. [...]there are more than 60 vaccines undergoing clinical trial at the moment, including 20 in phase 3 trials. · This was the fastest vaccine development program in history, and it's not even close. [...]the COVID-19 pandemic, the fastest development timeline was 4 years, for the mumps vaccine. · Many government systems moved quickly to lessen the burden of onerous regulations and provide funding so that vaccines could be developed quickly but with rigorous standards. Perhaps it should be a lesson to all of us that regulation and innovation can be calibrated more effectively during "normal" times as industry races to develop new therapies for other epidemics-cancer, diabetes, heart disease, and more.

10.
Oncology ; 2021.
Article in English | ProQuest Central | ID: covidwho-2296380
11.
Oncology ; 2021.
Article in English | ProQuest Central | ID: covidwho-2296379
12.
Contemporary Pediatrics ; 38(11):5, 2021.
Article in English | ProQuest Central | ID: covidwho-1529328
13.
Contemporary Pediatrics ; 38(10):5, 2021.
Article in English | ProQuest Central | ID: covidwho-1505354
14.
Contemporary Pediatrics ; 38(9):5, 2021.
Article in English | ProQuest Central | ID: covidwho-1451587
15.
Contemporary Pediatrics ; 38(5):5, 2021.
Article in English | ProQuest Central | ID: covidwho-1245145
16.
Contemporary Pediatrics ; 38(4):3, 2021.
Article in English | ProQuest Central | ID: covidwho-1206678
17.
Contemporary Pediatrics ; 37(11):8, 2020.
Article in English | ProQuest Central | ID: covidwho-948357
SELECTION OF CITATIONS
SEARCH DETAIL